Glucagon secretion: molecular mechanisms & dependencies

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

Human evidence only

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

The inhibitory neurotransmitter GABA is present in the endocrine part of the pancreas at concentrations comparable to those encountered in the central nervous system and co-localizes with insulin in pancreatic beta cells, and we describe a mechanism whereby GABA co-secreted with insulin from beta cells may mediate part of the inhibitory action of glucose on glucagon secretion by activating GABA-A receptor chloride channels in alpha 2 cells, providing a model for feedback regulation of glucagon release which may be of significance for understanding the hypersecretion of glucagon frequently associated with diabetes.
Gamma-aminobutyric acid → Glucagon secretion source_derived_draftungraded
Experimental context and source evidence
evidence_span
{"source_cache": "artifacts/gaba-research/2550826.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9062539804213a1ccf427b75c8f6d262b151e22464cd6b7c84640f222f7dea94", "start_char": 0, "end_char": 1225, "text_sha256": "9062539804213a1ccf427b75c8f6d262b151e22464cd6b7c84640f222f7dea94"}
experimental_model
Electrophysiology of pancreatic alpha 2 cells with glucose and GABA
exposure
GABA co-secreted with insulin from beta cells, acting on GABA-A receptor chloride channels in alpha 2 cells
limitations
An early electrophysiological model. It proposes that GABA mediates part of the effect of glucose rather than demonstrating the whole of it.
nutrient_topic
GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
organism
Guinea pig and rat
plain_language
The cells that release insulin release GABA with it, and that is part of how a meal switches off the opposing hormone.
primary_references
[gb-p2550826] Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. (1989). https://pubmed.ncbi.nlm.nih.gov/2550826/ DOI: 10.1038/341233a0
tissue_or_cell_type
Pancreatic islet
GABA: a ligand with no sign of its own, the cofactor that limits its synthesis, the barrier that keeps it out of the brain, and the immune settings where the same molecule protects and harms (2026-09-22) · lines 404–415
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Electrophysiology of pancreatic alpha 2 cells with glucose and GABA · source_derived_draft · unverified_draft
### gb-the-islet-signals-with-gaba The inhibitory neurotransmitter GABA is present in the endocrine part of the pancreas at concentrations comparable to those encountered in the central nervous system and co-localizes with insulin in pancreatic beta cells, and we describe a mechanism whereby GABA co-secreted with insulin from beta cells may mediate part of the inhibitory action of glucose on glucagon secretion by activating GABA-A receptor chloride channels in alpha 2 cells, providing a model for feedback regulation of glucagon release which may be of significance for understanding the hypersecretion of glucagon frequently associated with diabetes. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: The cells that release insulin release GABA with it, and that is part of how a meal switches off the opposing hormone. organism: Guinea pig and rat tissue_or_cell_type: Pancreatic islet experimental_model: Electrophysiology of pancreatic alpha 2 cells with glucose and GABA limitations: An early electrophysiological model. It proposes that GABA mediates part of the effect of glucose rather than demonstrating the whole of it. exposure: GABA co-secreted with insulin from beta cells, acting on GABA-A receptor chloride channels in alpha 2 cells evidence_span: {"source_cache": "artifacts/gaba-research/2550826.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9062539804213a1ccf427b75c8f6d262b151e22464cd6b7c84640f222f7dea94", "start_char": 0, "end_char": 1225, "text_sha256": "9062539804213a1ccf427b75c8f6d262b151e22464cd6b7c84640f222f7dea94"} [gb-p2550826] Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. (1989). https://pubmed.ncbi.nlm.nih.gov/2550826/ DOI: 10.1038/341233a0
Complete structured claim and evidence
Rat beta-cells release GABA by calcium-dependent exocytosis of synaptic-like microvesicles and the GABA thus released can diffuse over sufficient distances within the islet interstitium to activate GABA-A receptors in neighboring cells, confocal immunocytochemistry revealed the presence of GABA-A receptors in glucagon-secreting alpha-cells but not in beta- and delta-cells with transcripts of alpha1, alpha4 and beta1-3 subunits detected in purified alpha-cells but not in beta-cells, the antagonist SR95531 increased glucagon secretion at 1 millimolar glucose twofold and completely abolished the inhibitory action of 20 millimolar glucose on glucagon release, and basal and glucose-stimulated secretion of insulin and somatostatin were unaffected.
SR95531, a GABA-A receptor antagonist → Glucagon secretion source_derived_draftungraded
Experimental context and source evidence
evidence_span
{"source_cache": "artifacts/gaba-research/15047619.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1f64e75f4c5822ecc05331804e4d127c8b1702249327c4ed85fa07d96898d5b0", "start_char": 0, "end_char": 1478, "text_sha256": "1f64e75f4c5822ecc05331804e4d127c8b1702249327c4ed85fa07d96898d5b0"}
experimental_model
Confocal immunocytochemistry, transcript analysis, whole-cell voltage clamp and hormone secretion with a receptor antagonist
exposure
Endogenous GABA released from beta cells, with the GABA-A antagonist SR95531 and the calcium channel blocker isradipine
limitations
The antagonist experiment is what makes this causal for the endogenous signal. Receptor detection was by immunocytochemistry and transcripts in purified cells.
nutrient_topic
GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
organism
Rat
plain_language
Block the receptor and glucose stops switching off glucagon entirely, and the receptor is on the glucagon cell and not on the insulin cell.
primary_references
[gb-p15047619] Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. (2004). https://pubmed.ncbi.nlm.nih.gov/15047619/ DOI: 10.2337/diabetes.53.4.1038
tissue_or_cell_type
Purified islet cells and intact islets
GABA: a ligand with no sign of its own, the cofactor that limits its synthesis, the barrier that keeps it out of the brain, and the immune settings where the same molecule protects and harms (2026-09-22) · lines 417–428
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Confocal immunocytochemistry, transcript analysis, whole-cell voltage clamp and hormone secretion with a receptor antagonist · source_derived_draft · unverified_draft
### gb-the-receptor-is-on-the-alpha-cell-only Rat beta-cells release GABA by calcium-dependent exocytosis of synaptic-like microvesicles and the GABA thus released can diffuse over sufficient distances within the islet interstitium to activate GABA-A receptors in neighboring cells, confocal immunocytochemistry revealed the presence of GABA-A receptors in glucagon-secreting alpha-cells but not in beta- and delta-cells with transcripts of alpha1, alpha4 and beta1-3 subunits detected in purified alpha-cells but not in beta-cells, the antagonist SR95531 increased glucagon secretion at 1 millimolar glucose twofold and completely abolished the inhibitory action of 20 millimolar glucose on glucagon release, and basal and glucose-stimulated secretion of insulin and somatostatin were unaffected. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: Block the receptor and glucose stops switching off glucagon entirely, and the receptor is on the glucagon cell and not on the insulin cell. organism: Rat tissue_or_cell_type: Purified islet cells and intact islets experimental_model: Confocal immunocytochemistry, transcript analysis, whole-cell voltage clamp and hormone secretion with a receptor antagonist limitations: The antagonist experiment is what makes this causal for the endogenous signal. Receptor detection was by immunocytochemistry and transcripts in purified cells. exposure: Endogenous GABA released from beta cells, with the GABA-A antagonist SR95531 and the calcium channel blocker isradipine evidence_span: {"source_cache": "artifacts/gaba-research/15047619.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1f64e75f4c5822ecc05331804e4d127c8b1702249327c4ed85fa07d96898d5b0", "start_char": 0, "end_char": 1478, "text_sha256": "1f64e75f4c5822ecc05331804e4d127c8b1702249327c4ed85fa07d96898d5b0"} [gb-p15047619] Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. (2004). https://pubmed.ncbi.nlm.nih.gov/15047619/ DOI: 10.2337/diabetes.53.4.1038
Complete structured claim and evidence

The events it takes part in

A mechanism often involves more than two components. These are the full events, with every participant and its role.

Situations it appears in

Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

Open hypotheses

Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.

This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

Glucagon secretion